NCT02799823View on ClinicalTrials.gov

Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Early Feasibility Trial

NATerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 27, 2017

Primary Completion Date

January 20, 2023

Study Completion Date

January 20, 2023

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

HLT Transcatheter Aortic Valve System

Transcatheter aortic valve replacement with HLT Transcatheter Aortic Valve System

Trial Locations (5)

10016

NYU Langone Medical Center, New York

20010

MedStar Health, Washington D.C.

45219

The Lindner Center for Research and Education at the Christ Hospital, Cincinnati

46290

St. Vincent Heart Center of Indiana, Indianapolis

75093

Baylor Scott & White The Heart Hospital Plano, Plano

Sponsors

Lead Sponsor

HLT Inc.
All Listed Sponsors
lead

HLT Inc.

INDUSTRY

NCT02799823 - Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Early Feasibility Trial | Biotech Hunter | Biotech Hunter